Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02795156
Title Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications

larynx cancer

lung non-small cell carcinoma

vestibule of mouth cancer

biliary tract cancer

pancreatic cancer

nasal cavity cancer

paranasal sinus cancer

gum cancer

tonsil cancer

lip cancer

liver cancer

gastroesophageal cancer

transitional cell carcinoma

salivary gland cancer

oropharynx cancer

nasopharynx carcinoma

oral cavity cancer

tongue cancer

Therapies

Cabozantinib

Afatinib

Regorafenib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthOne Denver Colorado 80218 United States Details
Florida Cancer Specialists - South Fort Myers Florida 33916 United States Details
Florida Cancer Specialists - North Saint Petersburg Florida 33705 United States Details
Florida Cancer Specialists - East West Palm Beach Florida 33401 United States Details
Research Medical Center - HCA Midwest Kansas City Missouri 64132 United States Details
Tennesse Oncology Chattanooga Tennessee 37404 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field